Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MOPP-ABV hybrid protocol

Known as: MOPP/ABV Hybrid Regimen, Mustargen-Oncovin-Procarbazine-Prednisone plus Adriamycin-Bleomycin-Vinblastine Hybrid Regimen 
A non-cross resistant regimen in which half of the MOPP regimen is administered with half of the ABV regimen and is used for the initial treatment of… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The institution affiliation section on page 1638 of the April 1997 article entitled, "Treatment of Advanced Hodgkin's Disease… Expand
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BackgroundProventricular dilatation disease (PDD) is a fatal disorder of psittacine birds worldwide. The disease is characterized… Expand
  • table 1
Is this relevant?
Highly Cited
2003
Highly Cited
2003
BACKGROUND The use of involved-field radiotherapy after chemotherapy for advanced Hodgkin's lymphoma is controversial. METHODS… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2000
2000
BACKGROUND Combination chemotherapy, including hybrid regimens, is the standard treatment for patients with advanced Hodgkin… Expand
Is this relevant?
1999
1999
Knowledge Discovery in Databases (also known as Data Mining) is a powerful paradigm for automated knowledge acquisition. In this… Expand
  • figure 1
  • figure 2
  • table 1
  • table 2
  • table 3
Is this relevant?
1998
1998
PURPOSE To compare the efficacy of sequential mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) followed by… Expand
Is this relevant?
Highly Cited
1997
Highly Cited
1997
PURPOSE This randomized, prospective trial compares outcomes for patients with advanced Hodgkin's disease treated with… Expand
Is this relevant?
1992
1992
A 43-year-old man presented with simultaneously occurring alopecia areata and stage IIIB nodular sclerosing Hodgkin's disease… Expand
Is this relevant?
1992
1992
PURPOSE To determine the incidence of a second malignancy in patients with Hodgkin's disease (HD) diagnosed and treated in the… Expand
Is this relevant?
1981
1981
From 1970 to 1975 patients with Stage IV Hodgkin's disease randomised for treatment in the British National Lymphoma… Expand
Is this relevant?